Cellective Therapeutics Inc

Registration country: 
United States
ISIC Code: 
2100
Overview: 
Cellective Therapeutics, Inc., a drug development company, engages in discovering, developing, and commercializing monoclonal antibodies for the treatment of B-cell cancers and autoimmune diseases. Its products include monoclonal antibodies that target the B-cell antigens CD19, CD20, and CD22 are in preclinical stage programs.